PathFinder: Bayesian inference of clone migration histories in cancer.
暂无分享,去创建一个
Maxwell D. Sanderford | Sudhir Kumar | K. Tamura | Sayaka Miura | Tracy Vu | Olumide Oladeinde | A. Chroni | Vivian Aly
[1] Sudhir Kumar,et al. Power and pitfalls of computational methods for inferring clone phylogenies and mutation orders from bulk sequencing data , 2020, Scientific Reports.
[2] A. Jemal,et al. Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.
[3] Mark D. M. Leiserson,et al. PhySigs: Phylogenetic Inference of Mutational Signature Dynamics , 2019, PSB.
[4] Sudhir Kumar,et al. Delineation of Tumor Migration Paths by Using a Bayesian Biogeographic Approach , 2019, Cancers.
[5] Jeffrey H. Chuang,et al. Molecular Biology and Evolution of Cancer: From Discovery to Action , 2019, Molecular biology and evolution.
[6] Marc J. Williams,et al. Measuring Clonal Evolution in Cancer with Genomics. , 2019, Annual review of genomics and human genetics.
[7] D. Welch,et al. Defining the Hallmarks of Metastasis. , 2019, Cancer research.
[8] David Posada,et al. Rapid evolution and biogeographic spread in a colorectal cancer , 2019, Nature Communications.
[9] Sudhir Kumar,et al. Predicting clone genotypes from tumor bulk sequencing of multiple samples , 2018, bioRxiv.
[10] Benjamin J. Raphael,et al. Inferring Parsimonious Migration Histories for Metastatic Cancers , 2018, Nature Genetics.
[11] Yong Wang,et al. Single-cell DNA sequencing reveals a late-dissemination model in metastatic colorectal cancer , 2017, Genome research.
[12] P. Lønning,et al. Genomic Evolution of Breast Cancer Metastasis and Relapse , 2017, Cancer cell.
[13] Lajos Pusztai,et al. Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations , 2017, Nature Communications.
[14] J. Townsend,et al. PhyloOncology: Understanding cancer through phylogenetic analysis. , 2017, Biochimica et biophysica acta. Reviews on cancer.
[15] Y. Chung,et al. Intraindividual genomic heterogeneity of high‐grade serous carcinoma of the ovary and clinical utility of ascitic cancer cells for mutation profiling , 2017, The Journal of pathology.
[16] Christopher A. Miller,et al. Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases , 2016, PLoS medicine.
[17] Stephen Fox,et al. The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program “CASCADE” , 2016, PLoS medicine.
[18] Nam Huh,et al. Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination , 2015, Proceedings of the National Academy of Sciences.
[19] M. Nykter,et al. The Evolutionary History of Lethal Metastatic Prostate Cancer , 2015, Nature.
[20] Sohrab P. Shah,et al. Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution , 2014, Nature.
[21] M. Nei,et al. A new method of inference of ancestral nucleotide and amino acid sequences. , 1995, Genetics.